Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amadeo Pesce

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Opioid Management|September 25, 2024
Why pharmacogenetic testing should be reimbursed by Medicare and commercial health insuranceAmadeo Pesce
MLO: Medical Laboratory Observer|March 31, 2011
Drugs-of-abuse testing and therapeutic-drug monitoringAmadeo Pesce, Cameron West
Pain Physician|February 2, 2010
A tale of two drug testing technologies: GC-MS and LC-MS/MSCharles Mikel, Amadeo Pesce, Cameron West
Pain Physician|March 21, 2012
3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic painCharles Mikel, Amadeo Pesce, Cameron West
Journal of Analytical Toxicology|December 26, 2016
Positive Predictive Value of PCP Immunoassay at UC San Diego HealthImir G Metushi, Robert Fitzgerald, Amadeo Pesce
Annals of Clinical and Laboratory Science|July 12, 2023
Estimates of Drug Metabolism Using Drug Excretion ConcentrationsAgnes Cua, Kevin Krock, Richard Thomas, et al.
Annals of Clinical and Laboratory Science|August 25, 2023
<i>Letter to Editor:</i> Observations of Deception in Urine Drug TestingAgnes Cua, Kevin Krock, Richard Thomas, et al.
Pain Medicine (Malden, Mass.)|April 13, 2012
Interpretation of urine drug testing in pain patientsAmadeo Pesce, Cameron West, Kathy Egan City, et al.
Annals of Clinical and Laboratory Science|March 8, 2023
Changing Landscape of Fentanyl/Heroin Use and DistributionAmadeo Pesce, Nicholas Bevins, Keith Tran, et al.
Annals of Clinical and Laboratory Science|October 19, 2022
Update: Correlation of Fentanyl Positive Drug Screens with other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsAmadeo Pesce, Keith Tran, Richard Thomas, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Opioid Management|September 25, 2024
Why pharmacogenetic testing should be reimbursed by Medicare and commercial health insuranceAmadeo Pesce
MLO: Medical Laboratory Observer|March 31, 2011
Drugs-of-abuse testing and therapeutic-drug monitoringAmadeo Pesce, Cameron West
Pain Physician|February 2, 2010
A tale of two drug testing technologies: GC-MS and LC-MS/MSCharles Mikel, Amadeo Pesce, Cameron West
Pain Physician|March 21, 2012
3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic painCharles Mikel, Amadeo Pesce, Cameron West
Journal of Analytical Toxicology|December 26, 2016
Positive Predictive Value of PCP Immunoassay at UC San Diego HealthImir G Metushi, Robert Fitzgerald, Amadeo Pesce
Annals of Clinical and Laboratory Science|July 12, 2023
Estimates of Drug Metabolism Using Drug Excretion ConcentrationsAgnes Cua, Kevin Krock, Richard Thomas, et al.
Annals of Clinical and Laboratory Science|August 25, 2023
<i>Letter to Editor:</i> Observations of Deception in Urine Drug TestingAgnes Cua, Kevin Krock, Richard Thomas, et al.
Pain Medicine (Malden, Mass.)|April 13, 2012
Interpretation of urine drug testing in pain patientsAmadeo Pesce, Cameron West, Kathy Egan City, et al.
Annals of Clinical and Laboratory Science|March 8, 2023
Changing Landscape of Fentanyl/Heroin Use and DistributionAmadeo Pesce, Nicholas Bevins, Keith Tran, et al.
Annals of Clinical and Laboratory Science|October 19, 2022
Update: Correlation of Fentanyl Positive Drug Screens with other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsAmadeo Pesce, Keith Tran, Richard Thomas, et al.
Pageof 4